Back to Search
AGOP BEDIKIAN, M.D.
M.D.
Medical Oncology Physician
NPI: 1518066521Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
E6724(TX)
Research & Publications (20)
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
PMID 19440934·Cancer Invest·2009
3-trial
A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
PMID 19011511·Melanoma Res·2008
2-rct
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
PMID 18584354·Cancer Invest·2008
8-other
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
PMID 18569391·J Immunotoxicol·2008
4-observational
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
PMID 16966688·J Clin Oncol·2006
2-rct
Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
PMID 16809798·J Clin Pharmacol·2006
3-trial
Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.
PMID 15091196·Melanoma Res·2004
3-trial
Phase II evaluation of temozolomide in metastatic choroidal melanoma.
PMID 12777987·Melanoma Res·2003
3-trial
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
PMID 19521262·Melanoma Res·2009
3-trial
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
PMID 19506454·Am J Clin Oncol·2009
3-trial
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
PMID 19430405·Melanoma Res·2009
3-trial
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).
PMID 19419855·Eur J Cancer·2009
4-observational
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
PMID 19002462·Cancer Chemother Pharmacol·2009
3-trial
Biochemotherapy in patients with advanced head and neck mucosal melanoma.
PMID 18798304·Head Neck·2008
8-other
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
PMID 18728664·Br J Cancer·2008
3-trial
A phase II trial of arsenic trioxide in patients with metastatic melanoma.
PMID 16130126·Cancer·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1518066521
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile